SB-249553 Uses, Dosage, Side Effects and more

SB-249553 is a vaccine that has MAGE-3 cancer antigen and the Adjuvant SBAS-2. It is also under by GlaxoSmithKline to treat melanoma and lung cancer.

Trade Name SB-249553
Generic SB-249553
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

lung cancer/melanoma

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share